Propylthiouracil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00550 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 2 | neonatal thyrotoxicosis | KG + DL |
| 3 | hyperthyroxinemia | KG + DL |
| 4 | Hashimoto thyroiditis | KG + DL |
| 5 | autoimmune thyroid disease | KG + DL |
| 6 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 7 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 8 | diabetic nephropathy | KG + DL |
| 9 | Prinzmetal angina | KG + DL |
| 10 | primary hereditary glaucoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.